Christopher Cuniasse, managing director of Fagron France, sheds light on the specialty area of pharmaceutical compounding and its link with personalized medicine, noting the benefits it can deliver to health professionals, patients, the pharma industry, and healthcare systems. As a newly implemented leader tasked with growing the affiliate and developing its activities in France, Cuniasse goes on to explain how he is taking on this challenge through strong reprioritization and communication efforts.
In a nutshell, Fagron is now addressing doctors as new partners in France to help them find the most appropriate personalized treatment for their patients
